Prostate cancer: Dutasteride--a welcome addition to active surveillance?
- PMID: 22331096
- DOI: 10.1038/nrurol.2012.12
Prostate cancer: Dutasteride--a welcome addition to active surveillance?
Comment on
-
Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial.Lancet. 2012 Mar 24;379(9821):1103-11. doi: 10.1016/S0140-6736(11)61619-X. Epub 2012 Jan 24. Lancet. 2012. PMID: 22277570 Clinical Trial.
References
-
- Lancet. 2012 Mar 24;379(9821):1103-11 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
